Marshall Wace, LLP Verrica Pharmaceuticals Inc. Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$5.32 - $6.79 $215,577 - $275,144
40,522 Added 302.22%
53,930 $311,000
Q1 2023

May 15, 2023
BUY
$2.88 - $8.51 $38,615 - $114,102
13,408 New
13,408 $87,000
Q2 2021

Aug 13, 2021
BUY
$9.77 - $15.33 $307,022 - $481,745
31,425 New
31,425 $355,000

Others Institutions Holding VRCA

# of Institutions
71
Shares Held
17.4M
Call Options Held
6.1K
Put Options Held
6.3K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email